GB2354708B - Compositions for the treatment of wound contracture - Google Patents

Compositions for the treatment of wound contracture

Info

Publication number
GB2354708B
GB2354708B GB9923291A GB9923291A GB2354708B GB 2354708 B GB2354708 B GB 2354708B GB 9923291 A GB9923291 A GB 9923291A GB 9923291 A GB9923291 A GB 9923291A GB 2354708 B GB2354708 B GB 2354708B
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
wound contracture
contracture
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9923291A
Other languages
English (en)
Other versions
GB9923291D0 (en
GB2354708A (en
Inventor
Breda Mary Cullen
Derek Walter Silcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Priority to GB9923291A priority Critical patent/GB2354708B/en
Publication of GB9923291D0 publication Critical patent/GB9923291D0/en
Priority to AU75381/00A priority patent/AU7538100A/en
Priority to JP2001527840A priority patent/JP2003511099A/ja
Priority to EP00964446A priority patent/EP1216066A1/en
Priority to PCT/GB2000/003744 priority patent/WO2001024841A1/en
Publication of GB2354708A publication Critical patent/GB2354708A/en
Application granted granted Critical
Publication of GB2354708B publication Critical patent/GB2354708B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
  • Woven Fabrics (AREA)
GB9923291A 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture Expired - Fee Related GB2354708B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB9923291A GB2354708B (en) 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture
AU75381/00A AU7538100A (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture
JP2001527840A JP2003511099A (ja) 1999-10-01 2000-09-29 酸化セルロースの使用方法
EP00964446A EP1216066A1 (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture
PCT/GB2000/003744 WO2001024841A1 (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9923291A GB2354708B (en) 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture

Publications (3)

Publication Number Publication Date
GB9923291D0 GB9923291D0 (en) 1999-12-08
GB2354708A GB2354708A (en) 2001-04-04
GB2354708B true GB2354708B (en) 2004-06-02

Family

ID=10861983

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9923291A Expired - Fee Related GB2354708B (en) 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture

Country Status (5)

Country Link
EP (1) EP1216066A1 (ja)
JP (1) JP2003511099A (ja)
AU (1) AU7538100A (ja)
GB (1) GB2354708B (ja)
WO (1) WO2001024841A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105401242A (zh) * 2015-10-23 2016-03-16 徐爱军 具有抗菌消炎功效的医用无纺布及制备方法

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2373724B (en) * 2001-03-28 2005-02-02 Johnson & Johnson Medical Ltd Peptides for the treatment of wound contracture
CA2495541C (en) 2002-09-11 2011-07-12 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
EP1601388B1 (en) * 2003-03-10 2011-04-27 Johnson & Johnson Medical Ltd. Hydrocolloid materials for use in wound healing
GB2399289B (en) * 2003-03-10 2006-03-08 Johnson & Johnson Medical Ltd Hydrocolloid materials for use in wound healing
EP2720667A2 (en) * 2011-06-16 2014-04-23 Unilever PLC Aqueous gels
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
CN104368049B (zh) * 2014-11-12 2017-02-15 无锡中科光远生物材料有限公司 氧化纤维素体系的止血防粘连的复合材料及其制备方法
CN107530212B (zh) * 2015-04-24 2021-10-26 郡是株式会社 生物组织加固材料
CN108348633B (zh) 2015-11-06 2022-07-08 伊西康公司 压实止血纤维素聚集体
US10137220B2 (en) 2015-11-08 2018-11-27 Omrix Biopharmaceuticals Ltd. Hemostatic composition
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
JP6868129B2 (ja) * 2017-10-13 2021-05-12 グンゼ株式会社 生体組織補強材料キット及び生体組織補強材料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038737A1 (en) * 1996-04-16 1997-10-23 Eastman Chemical Company Oxidised cellulose and vitamin e blend for topical hemostatic applications
GB2314842A (en) * 1996-06-28 1998-01-14 Johnson & Johnson Medical Protein/oxidised regenerated cellulose complexes
GB2314840A (en) * 1996-06-28 1998-01-14 Johnson & Johnson Medical Oxidized oligosaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808599D0 (en) * 1988-04-12 1988-05-11 Glaxo Group Ltd Medicaments
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
US5601579A (en) * 1994-12-29 1997-02-11 Medex, Inc. Method for the treatment of bowel adhesions
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US5795286A (en) * 1996-08-15 1998-08-18 Cathco, Inc. Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038737A1 (en) * 1996-04-16 1997-10-23 Eastman Chemical Company Oxidised cellulose and vitamin e blend for topical hemostatic applications
GB2314842A (en) * 1996-06-28 1998-01-14 Johnson & Johnson Medical Protein/oxidised regenerated cellulose complexes
GB2314840A (en) * 1996-06-28 1998-01-14 Johnson & Johnson Medical Oxidized oligosaccharides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105401242A (zh) * 2015-10-23 2016-03-16 徐爱军 具有抗菌消炎功效的医用无纺布及制备方法

Also Published As

Publication number Publication date
JP2003511099A (ja) 2003-03-25
GB9923291D0 (en) 1999-12-08
EP1216066A1 (en) 2002-06-26
AU7538100A (en) 2001-05-10
WO2001024841A1 (en) 2001-04-12
GB2354708A (en) 2001-04-04

Similar Documents

Publication Publication Date Title
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
PL350618A1 (en) Use of xenon for treating neurointoxications
HK1038691A1 (en) Antibiotic compositions for treatment of the eye
GB0015724D0 (en) Malodour treatment compositions
GB2354708B (en) Compositions for the treatment of wound contracture
GB0029138D0 (en) Wound treatment composition
HUP0002509A3 (en) Combination composition for treatment of migraine
GB9925136D0 (en) Novel treatment
HUP0200738A3 (en) Method of the treatment of incontinence
PL349347A1 (en) Novel treatment
IL133760A0 (en) Composition for the treatment of dandruff
HK1043938A1 (en) Composition for the treatment of psoriasis
HUP0001891A3 (en) Medicament for the treatment of migraine
GB2363604B (en) S-nitrosothiols as agents for the treatment of circulatory dsyfunctions
GB9904252D0 (en) Composition for the treatment of pain
EP1175834A4 (en) METHOD OF USING BACTERICIDE COMPOSITION
GB9917160D0 (en) Maldour treatment compositions
EP1158991A4 (en) ASTHMA TREATMENT
HUP0202791A3 (en) Pharmaceutical compositions for treating psoriasis
GB9918000D0 (en) Compositions for the treatment of pain
IL124878A0 (en) Composition for the treatment of seborrhea
GB9917133D0 (en) Malodour treatment compositions
GB9922080D0 (en) Malodour treatment compositions
GB9916655D0 (en) Novel treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20071001